Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) Other Operating Expenses (2020 - 2025)

Beauty Health (SKIN) has disclosed Other Operating Expenses for 6 consecutive years, with $23.5 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 11.36% to $23.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $93.6 million through Dec 2025, down 20.89% year-over-year, with the annual reading at $93.6 million for FY2025, 20.89% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $23.5 million at Beauty Health, up from $20.9 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $44.9 million in Q2 2022, with the low at $602319.0 in Q1 2021.
  • Average Other Operating Expenses over 5 years is $30.5 million, with a median of $30.6 million recorded in 2023.
  • The sharpest move saw Other Operating Expenses skyrocketed 1977237.66% in 2021, then decreased 29.18% in 2024.
  • Over 5 years, Other Operating Expenses stood at $37.1 million in 2021, then grew by 5.31% to $39.0 million in 2022, then decreased by 17.93% to $32.0 million in 2023, then fell by 17.17% to $26.5 million in 2024, then fell by 11.36% to $23.5 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $23.5 million, $20.9 million, and $23.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.